Core Viewpoint - The incident involving Zhang, who claims that iKang Guobin failed to detect her cancer after ten years of health check-ups, has sparked significant outrage from both the customer and the company, leading to a public relations crisis for iKang Guobin [1][2]. Group 1: Company Response - iKang Guobin held a press conference to express their anger rather than apologizing or comforting the customer, and they have initiated legal action against her [2]. - The CEO of iKang Guobin stated, "Do not expect a health check costing a few hundred yuan to detect all diseases," which has become a focal point of public discourse [3]. Group 2: AI and Communication - The company's public statement was perceived as highly templated and lacking genuine human touch, leading to speculation that it may have been generated by AI [4][6]. - The use of AI in crafting the response has raised concerns about trust, as AI lacks the human elements of responsibility, experience, and intent that are crucial for effective communication [11][15]. Group 3: Crisis Management - Effective crisis communication requires acknowledging emotions and building trust, which iKang Guobin failed to do by focusing on their own anger rather than addressing customer fears [20][34]. - The absence of human elements in the communication process can lead to a lack of reflection and an amplification of irrational responses, as AI does not provide the necessary checks and balances that human involvement would [26][28]. Group 4: Broader Implications - The incident highlights a broader issue in corporate communication, where the desire for efficiency and safety can undermine the value of genuine human interaction [39][41]. - The reliance on AI for communication tasks may lead to a superficial approach that fails to address the complexities of human relationships and trust-building [40][46].

Core Viewpoint - The CEO of Aikang Group, Zhang Ligang, emphasized the clear distinction between health check-ups and medical consultations, stating that health check-ups are primarily for disease prevention and risk identification, while medical consultations are for definitive diagnosis and treatment [1][4]. Group 1: Media Misrepresentation - Some media outlets misinterpreted Zhang Ligang's comments, reducing them to the phrase "don't expect a few hundred yuan check-up to detect any illness," which stripped the context and distorted the original meaning [1][2][4]. - The media's simplification of the discussion on the differences between health check-ups and medical consultations misled the public regarding the value of health check-ups, violating principles of objective and comprehensive reporting [2][4]. Group 2: Commitment to Professionalism - Aikang Group asserts that it will not compromise the professionalism of its services, regardless of the price of health check-up packages, maintaining a commitment to customer-centric health management services [2][5]. - The company aims to provide rigorous health management services and emphasizes that the cost of check-up packages does not affect the quality of service provided [2][5].

近日，律师张女士称十年体检未有"患癌风险"预警，确诊已是肾癌晚期。对此，7月30日，爱康国宾举办媒体说明 会。南都N视频记者获悉，爱康国宾有关负责人否认"假体检"，并称爱康已向人民法院提起诉讼，获法院受理并 立案。对此，张女士回应，要求把自己的10年超声检查、检查人员名单和资质、第三方机构、起诉内容等情况对 外公布。 爱康国宾称已起诉 "体检要做什么项目，某种程度不是医生说了算的，是公司人事部说了算的。所以到体检中心做体检，套餐里有什 么就是做什么。"围绕体检、看病间的区别这一话题，爱康集团创始人、董事长兼CEO张黎刚称，在看病模式下， 病人做什么项目，不是套餐说了算，而是专科医生说了算。如果体检按照看病模式来的话，可能一两天都查不 完。"体检模式是帮你发现各种问题后，体检医生详细描述发现的问题，做一定的风险提示，最终你应该去找专科 医生来进行确诊。" 张黎刚表示，"大家想一下，大多数企业给员工做体检，少的几百块，多的也就几千块钱。大家去医院看个病，你 要诊断某个病，你们问问自己，大概要花多少钱。当你指望说，一个几百块钱的体检能帮你什么病都查出来，而 要查单一的病，都花几千几万块钱的时候，你认为这样的情况存在 ...

近日，律师张女士称十年体检未有"患癌风险"预警，确诊已是肾癌晚期。对此，7月30日，爱康国宾举 办媒体说明会。 ...

Core Viewpoint - The controversy surrounding Aikang Guobin's health check services has intensified following allegations from lawyer Zhang Xiaoling regarding missed cancer diagnoses, leading to a formal lawsuit by the company against her for defamation [1][5][14] Group 1: Company Response - Aikang Guobin reiterated that there were no missed or erroneous diagnoses in Zhang's health checks and has filed a lawsuit for defamation based on her claims of "fabricating facts and spreading rumors" [1][5] - The company presented Zhang's 2023 health check report, which indicated potential issues but recommended further examinations, emphasizing the importance of regular follow-ups [3][4] - Aikang Guobin's CEO, Zhang Ligang, clarified that health checks are meant for risk assessment rather than definitive diagnoses, highlighting the limitations of low-cost health check packages [6][10] Group 2: Public and Media Reaction - Zhang Xiaoling has publicly welcomed the lawsuit and has called for Aikang Guobin to disclose her ten years of health check data, including ultrasound images and technician qualifications [4][5] - The company's statements regarding the nature of health checks have sparked significant public debate, with some media misrepresenting the CEO's comments, leading to accusations of defamation against the company [6][11][12] - Aikang Guobin reported a high volume of complaints on platforms like Black Cat Complaints, with 76.2% attributed to uncontrollable factors, while only 2.5% were related to medical service issues [14]

Core Viewpoint - The company, Aikang Group, has responded to allegations from a lawyer, Ms. Zhang, regarding a failure to detect kidney cancer during her ten years of health check-ups, asserting that there were no misdiagnoses or missed diagnoses in her medical evaluations [1][3][9] Group 1: Company Response - Aikang Group held a media briefing to address the claims made by Ms. Zhang, stating that an internal and external review confirmed the accuracy of her kidney examinations [1][3] - The company has filed a formal lawsuit against Ms. Zhang regarding her allegations, which has been accepted by the court [1][9] - Aikang Group provided detailed information about Ms. Zhang's health check data, equipment information, and quality control results to the relevant authorities [7] Group 2: Medical Evaluation Details - During her health check on October 9, 2023, at Aikang Group's Beijing West Branch, Ms. Zhang's ultrasound report indicated potential issues, including a left kidney hamartoma and a calcified lesion on the right kidney, with recommendations for further examination [3][8] - The company clarified that the cancer embryonic antigen (CEA) test, which Ms. Zhang referenced, is not relevant for early diagnosis of kidney cancer, as early detection primarily relies on imaging techniques [8]

Core Viewpoint - The company, Aikang Guobin, is taking legal action against a lawyer, Zhang, who claimed that her cancer was undetected during ten years of health check-ups, asserting that her allegations are false and damaging to the company's reputation [1][3]. Group 1: Company Response - Aikang Guobin has filed a lawsuit against Zhang for defamation, stating that her claims have harmed the dignity of its employees and misled the public about the private health examination industry [1][3]. - The company clarified that Zhang's health check-ups were part of a basic welfare package provided by the Beijing Lawyers Association, and she did not opt for any additional paid services except in 2017 [3]. - Aikang Guobin presented evidence from Zhang's recent health check-up, indicating the possibility of a renal tumor, and emphasized that the purpose of health examinations is to identify risk signals rather than provide definitive diagnoses [3][4]. Group 2: Industry Context - The company highlighted that over 4.8 million new cancer cases are diagnosed annually in China, with Aikang Guobin identifying approximately 15,000 cases, equating to one in every 320 diagnosed cancer patients [3]. - There have been multiple complaints against Aikang Guobin regarding inaccurate health reports and misdiagnoses, with a total of 1,220 complaints recorded on a consumer complaint platform [9]. - The company has undergone internal reviews and external expert evaluations, concluding that it bears no responsibility for Zhang's case and is open to third-party assessments [9].

"女律师体检10年未提示癌症"的体检门事件持续发酵。7月30日，身陷信任危机的爱康国宾官宣强势回 击动作。 在7月30日举行的媒体说明会上，爱康集团就"10年体检未预警肾癌"事件进行回应和澄清。会上爱康集 团高管郑重宣布：已就张女士虚构事实、散布谣言的侵权行为向法院提起正式诉讼，并获法院受理并立 案。 "张女士本应秉持职业操守，她却罔顾事实，通过造谣污蔑手段，通过网络媒体大肆发酵爱康国宾假体 检言论，开展了一场对爱康有组织的网暴。由于其行为严重损害爱康声誉，让每年约800万体检客户蒙 羞，更让民众对私营体检中心，乃至中国整个医疗行业产生不信任。在上述情况下，爱康认为，必须要 澄清事实，还原真相，爱康代表1.5万名爱康员工，向人民法院提请诉讼，现已正式立案受理。"公司高 管在会上表示。 对于爱康国宾今日的发布会，当事人张晓玲律师则告诉媒体，她已关注到，并录屏。 张晓玲表示，"我非常期待他们起诉我。目前还没看到对方发来的起诉状，没有接到任何通知。但已做 好100%的准备，随时应诉。" "体检不等于看病诊断" 发布会现场，爱康集团创始人、董事长兼CEO张黎刚提供了一组数字——中国每一年确诊的癌症患者大 约有480万 ...

Core Viewpoint - The company Aikang Guobin is facing public scrutiny and legal action following allegations from a client, Ms. Zhang, who claims that her cancer was not detected during ten years of health check-ups, leading to a lawsuit against her for defamation [2][6]. Group 1: Company Response - Aikang Guobin held a media briefing to address the allegations, stating that Ms. Zhang's health check on October 9, 2023, indicated a "possible renal hamartoma," which suggests a potential cancer diagnosis [2][3]. - The company emphasized that Ms. Zhang's health checks were part of a basic package provided by the Beijing Bar Association, and she had not purchased any additional services except in 2017 [3]. - Aikang Guobin's CEO, Zhang Ligang, commented on public misconceptions regarding the effectiveness of low-cost health checks, questioning the expectation that a basic check costing a few hundred yuan could detect all diseases [11]. Group 2: Public Reaction and Concerns - Public skepticism arose regarding the value of health checks if they fail to detect serious conditions, with many questioning the purpose of offering such services [3][11]. - Ms. Zhang publicly demanded transparency from Aikang Guobin, requesting the release of her past ultrasound results and the qualifications of the personnel involved in her checks [6][11]. - Complaints against Aikang Guobin have surged, with over a thousand reports on platforms like Black Cat Complaints, citing issues such as inaccurate results and misleading practices [14]. Group 3: Industry Context - The incident has highlighted broader concerns within the health check industry, with previous allegations of malpractice and the existence of "fake health checks" being raised by industry insiders [14]. - The CEO's past revelations about the industry's integrity have come back to haunt him, as the company now faces a "crisis of trust" among the public [14].

Core Viewpoint - Aikang Group held a media briefing to address the recent controversy regarding a patient, Ms. Zhang, who claimed that her kidney cancer was not detected during ten years of health check-ups. The company denied any malpractice and announced a formal lawsuit against Ms. Zhang for defamation [1][3]. Group 1: Company Response - Aikang Group refuted allegations of diagnostic errors in Ms. Zhang's kidney examinations and stated that her claims about the ultrasound report were fabricated [3]. - The company emphasized that early diagnosis of kidney cancer primarily relies on imaging techniques (CT/MRI) rather than blood tests, as per the NCCN guidelines [3]. - Aikang Group provided evidence of quality control for Ms. Zhang's cancer marker tests, asserting that all data is traceable and available for government verification [3][4]. Group 2: Medical Practices and Regulations - Aikang Group explained that the preservation period for blood samples is typically 1-7 days, making it impossible to provide ten years' worth of samples as requested by Ms. Zhang [4]. - The company confirmed that all medical personnel are certified and that all equipment and reagents comply with national regulations, ensuring strict adherence to quality control standards [4]. Group 3: Patient History and Diagnosis - Aikang Group outlined Ms. Zhang's medical history, indicating that her ultrasound in October 2023 suggested possible kidney tumors, and subsequent tests led to a diagnosis of early-stage kidney cancer in November 2024 [5]. - It was noted that Ms. Zhang was later diagnosed with metastatic kidney cancer in February 2025 after further examinations [5]. Group 4: Public Perception and Misunderstanding - Aikang Group's CEO highlighted the public's misconceptions regarding the capabilities of routine health check-ups, stating that a basic health check cannot replace comprehensive medical diagnostics [7]. - The CEO pointed out that the cost of routine check-ups is significantly lower than that of specialized medical consultations, which may lead to unrealistic expectations from patients [7].